Long-acting growth hormone helps the era of comfort medicine evolve

On January 19, the Guangdong Provincial Drug Trading Center issued the "Guangdong Alliance Diclofenac and Other Drugs Centralized Procurement Documents", and a number of growth hormone drugs were included in the collection list. Recombinant human growth hormone, which has been on the market for decades, has also attracted the attention of the industry in recent years because of the research and development and availability of long-acting preparations, and has become another important drug research and development direction.

It is understood that Kinsey Pharmaceutical was first approved to market a long-acting growth hormone preparation in China - polyethylene glycolated growth hormone (Kinsey Increase). Its R & D personnel said that Kinsey's development of polyethylene glycol-based growth hormone, combined with PEG and waterborne growth hormone with natural peptide bonds, has a natural structure and can be filtered by the kidneys more slowly, realizing the once-a-week administration mode. In 2016, Kinsey Pharmaceutical won the second prize of the National Science and Technology Progress Award for "Development and Industrialization of Recombinant Human Growth Hormone Series Products".

In the era of comfort therapy, the birth of long-acting growth hormone is also in line with the practical needs of parents and children. From once a day to once a week, the pain of the patient is alleviated.

Under the situation of growth hormone collection, the research and development and promotion of long-acting growth hormone has become an important choice for growth hormone companies. In addition to developing products, Kinsey Pharmaceutical also optimizes the design of injection devices and drug delivery methods. For example, the hidden needle electronic pen is used to reduce children's fear, and the injection dose and time are transmitted to the cloud to facilitate disease management. According to the person in charge of Kinsey Pharmaceutical, Kinsey long-acting growth hormone electronic pen will be listed this year. (Promotion)

Source: Xinhua Finance